McMullen Michael R. bought BMY
December 31, 2025 · Form 4 insider transaction
McMullen Michael R. bought 649 shares of Bristol-Myers Squibb Company at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
649
Price
$0.00
Total value
N/A
InsiderMcMullen Michael R.
Role—
SecurityDeferred Share Units
Transaction codeA: Grant or award
Transaction dateDecember 31, 2025
Filing dateJanuary 5, 2026
Shares owned after10,861
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.; Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.